Evaluation of the cost-effectiveness of dexrazoxane for the prevention of anthracycline-related cardiotoxicity in children with sarcoma and haematologic malignancies: a European perspective

Overview of attention for article published in Cost Effectiveness and Resource Allocation, February 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 3 X users

Readers on

mendeley: 39 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 5,486 followers.

RT @HSRatBMC: Evaluation of the cost-effectiveness of dexrazoxane for the prevention of anthracycline-related cardiotoxicity in children wi…

15 Feb 2020

Reply Repost Favourite

Evaluation of the cost-effectiveness of dexrazoxane for the prevention of anthracycline-related cardiotoxicity in children with sarcoma and haematologic malignancies: a European perspective https://t.co/L4Ym20cjiE

13 Feb 2020

Reply Repost Favourite

12 Feb 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.